Spiro[cyclopropane-1,3'-pyrrolo[3,2-b]pyridin]-2'(1'H)-one

Catalog No. :
ACMZMV441
CAS No. :
1823958-83-3
Molecular Formula :
C9H8N2O
Molecular Weight :
160.18

IUPAC Name:spiro[cyclopropane-1,3'-pyrrolo[3,2-b]pyridin]-2'(1'H)-one

Spiro[cyclopropane-1,3'-pyrrolo[3,2-b]pyridin]-2'(1'H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$341.00Login to see priceInquiryInquiry
250mg95%$557.00Login to see priceInquiryInquiry
1g95%$1372.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSpiro[cyclopropane-1,3'-pyrrolo[3,2-b]pyridin]-2'(1'H)-one
IUPAC Namespiro[cyclopropane-1,3'-pyrrolo[3,2-b]pyridin]-2'(1'H)-one
MDL No.MFCD27922342
Molecular FormulaC9H8N2O
Molecular Weight160.18
SMILESO=C1NC2=CC=CN=C2C31CC3
InChI KeyHMFHPJNLRGOVIH-UHFFFAOYSA-N
Synonym3H-Spiro{cyclopropane-1,1-pyrrolo[3,2-b]pyridine}-2-one;SPIRO[CYCLOPROPANE-1,3-PYRROLO[3,2-B]PYRIDIN]-2(1H)-ONE;spiro[1H-pyrrolo[3,2-b]pyridine-3,1'-cyclopropane]-2-one;Spiro[cyclopropane-1,3'-[3H]pyrrolo[3,2-b]pyridin]-2'(1'H)-one;SPIRO[CYCLOPROPANE-1,3'-PYRROLO[3,2-B]PYRIDIN]-2'(1'H)-ONE
CAS No.1823958-83-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMZMV441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFHNM395 route compound structure diagram
    ACFHNM395185421-97-0 In Stock
  4. Then
  5. ACMZMV441 route product structure diagram
    ACMZMV4411823958-83-3
Inquiry

2. ACMZMV441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMZMV441 route product structure diagram
    ACMZMV4411823958-83-3
Inquiry

Comments (0)